ZimVie — Corporate Update (December 2023)
11 slides from ZimVie's corporate update, Dec 18, 2023
Slide 1: Business Update December 18, 2023
Business Update December 18, 2023 Exhibit 99.2
Slide 2: Forward-looking statements and Non-GAAP measures
Forward-looking statements and Non-GAAP measures Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-lo
Slide 3: Focused end-to-end dental company; divesting spine business
Focuses our strategy as an end-to-end dental company with a leading product portfolio Divesting spine business Builds a strong foundation for growth and value creation Announcing strategic simplification Improving growth profile and cash flow, while reducing leverage
Slide 4: Transaction overview
Transaction overview Proceeds net of tax and deal-related expenses. This is a non-GAAP financial measure for which a reconciliation to the most directly comparable GAAP financial measure is not available without unreasonable efforts. Refer to “Forward-looking statements and Non-GAAP measures” slide
Slide 5: Transaction will reposition ZimVie
Transaction will reposition ZimVie Where we are (dental and spine) Where we are going (2024+) Operating segments Facilities (Mfg./Offices/Distribution) Global distribution Employees 2 distinct businesses 1 pure-play dental company ~2,600 employees + ~500 3rd party commercial agents ~50% direct sales
Slide 6: ZimVie: Focused on global dental leadership
ZimVie: Focused on global dental leadership Powerful, market-leading portfolio of premium implants, biomaterials, and digital dentistry with exposure to MSD/HSD growth end-markets Well positioned to accelerate growth within large, attractive, and underserved markets through differentiated technologi
Slide 7: Significant, unmet need for tooth replacement
Significant, unmet need for tooth replacement 8 Million An estimated 8 million US patients seek treatment for tooth loss annually 25% Only 25% receive tooth replacement Leading player in the following attractive dental segments 2021 Market Opportunity 2021-2026E(1) CAGR Dental implants Biomaterials
Slide 8: Diversified dental portfolio addresses end-to-end patient needs
Diversified dental portfolio addresses end-to-end patient needs Increase Penetration of Implants through Continued Innovation and Commercial Execution Implant Growth: Innovation & Execution Leverage Leadership Position to Drive Implant Conversion Biomaterials Pull-Through Scale ZimVie Presence Acros
Slide 9: Fully integrated end-to-end implant-based tooth replacement solutions
Delivering fully integrated and end-to-end implant-based tooth replacement solutions Driving Premium Implant Growth Through Innovation Leveraging Biomaterials Leadership Position Digital Dentistry Driving Implant Adoption Comprehensive line of premium implant systems, meeting the varying needs of or
Slide 10: Financial outlook
Financial outlook Net Sales Adjusted EBITDA Margin(2) 2023 Guidance (Before impact due to Spine Business Divestiture Agreement)(1) Year 1 Post-Close $860M to $870M 13.5% to 14.0% $450M+ 15%+ Net Debt ~$440M(3) Drivers of financial progress Sales growth above market Operational simplification and eff
Slide 11: Long-term financial outlook
Long-term financial outlook Leverage innovation to grow above market Drive progress across the business to create long-term shareholder value Achieve 20%+ Adj EBITDA margin(1) 80%+ FCF Conversion(1,2) Achieve 2x operating leverage Innovation pipeline poised to accelerate growth in faster growing end